BIND Therapeutics Company
BIND Therapeutics isВ a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2006
Employees Number:
51-100
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Register and Claim Ownership